MOH — authorised 22 March 1950
- Marketing authorisation holder: BAXTER HLTHCARE
- Status: likely_approved
🇦🇪 Wydase in United Arab Emirates
MOH authorised Wydase on 22 March 1950
Marketing authorisation
Wydase in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United Arab Emirates
Frequently asked questions
Is Wydase approved in United Arab Emirates?
Yes. MOH authorised it on 22 March 1950.
Who is the marketing authorisation holder for Wydase in United Arab Emirates?
BAXTER HLTHCARE holds the UAE marketing authorisation.